The role of CXC chemokines in the regulation of angiogenesis

Chemical Immunology

Volumn 72, Issue , 1999, Pages 86-101

  Keane, Michael P ^a   Strieter, Robert M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANGIOGENIC FACTOR; CYTOKINE;

ANGIOGENESIS; CARCINOGENESIS; HUMAN; LUNG FIBROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0032800759     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058728     Document Type: Review

References (32)

1. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Stricter RM: In vitro and in vivo systems to assess the role of C-X-C chemokines in the regulation of angiogenesis. Methods Enzymol 1997;288:190-220.
2. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE, Hunter CA, Fox JC, Trinchieri G, Lee WMF: Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998;101:1441-1452.
3. Stricter RM, Kunkel SL, Einer VM, Martonyi CL, Koch AE, Polverini PJ, Einer SG: Interleukin-8. A corneal factor that induces neovascularizalion. Am J Pathol 1992;141:1279-1284.
4. Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S, Roczniak S, Shanafelt A: The functional role of the ELR motif in CXC chemokine-mcdiated angiogenesis. J Biol Chem 1995;270:27348-27357.
5. Neote K, Darbonne W, Ogez J, Horuk R, Schall T: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;268:985-991.
6. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A: Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am J Pathol 1995;147:1248-1260.
7. Luan J, Shattuck-Brandt R, Haghnegahdar H, Owen JD, Stricter R, Burdick M, Nirodi C, Beauchamp D, Johnson KN, Richmond A: Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997;62:588-597.
8. Miller LJ, Kurtzman SU, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL: Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 1998;18:77-81.
9. Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997;174:507-512.
10. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E: Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385:347-350.
11. Luster AD, Greenberg SM, Leder P: The IP-10 chemokinc binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995;182:219-231.
12. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Stricter RM: Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994;179:1409-1415.
13. Arenberg DA, Kunkel SL, Burdick MD, Polverini PJ, Stricter RM: Treatment with anti-IL-8 inhibits non-small cell lung cancer tumor growth (abstract). J Invest Med 1995;43(suppl 3):479A.
14. Yatsunami J, Tsuruta N, Ogata K, Wakamatsu K, Takayama K, Kkawasaki M, Nakanishi Y, Hara N, Hayashi S: Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett 1997;120:101-108.
15. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler U: Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998;90:447-454.
16. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54:3242-3247.
17. Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J: Gro-beta, a C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung cacinoma in mice. J Exp Med 1995;182:2069-2077.
18. Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Farber JM, Koniaris LG, Vanguri P, Burd PR, Sheikh N, Gupta G, Teruya-Feldstein J, Tosato G: Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA 1996;93:13791-13796.
19. Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wilson WH, Longo DL, Tosato G: The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90:4099-4105.
20. Sgadari C, Farber JM, Angiolillo AL, Liao F, Teruya-Feldstein J, Burd PR, Yao L, Gupta G, Kanegane C, Tosato G: Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood 1997;89:2635-2643.
21. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Stricter RM: Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996;184:931-992.
22. Carney DN: Cancers of the lungs; in Fishman AP (ed): Pulmonary Diseases and Disorders, ed 2. New York, McGraw-Hill, 1988, pp 1885-2068.
23. Yuan A, Yang PC, Yu CJ, Lee YC, Yao YT, Chen CL, Lee LN, Kuo SH, Luh KT: Tumor angiogenesis correlates with histologic type and metastasis in non-small cell lung cancer. Am J Respir Crit Care Med 1995;152:2157-2162.
24. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994;144:820-828.
25. Stricter RM, Polverini PJ, Arenberg DA, Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 1995;4:155-160.
26. Turner-Warwick M: Precapillary systemic-pulmonary anastomoses. Thorax 1963;18:225-237.
27. Peao MND, Aguas AP, DeSa CM, Grande NR: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994;238:57-67.
28. Keane MP, Arenberg DA, Lynch JP, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Stricter RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-1443.
29. Lynch JP, Standiford TJ, Kunkel SL, Rolfe MW, Stricter RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis: The role of interleukin-8. Am Rev Respir Dis 1992;145:1433-1438.
30. Koch AE, Leibovich SJ, Polverini PJ: Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 1986;29:471-479.
31. Stout AJ, Gresser I, Thompson WD: Inhibition of wound healing in mice by local interferon alpha/beta injection. Int J Exp Pathol 1993;74:79-85.
32. Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY: Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res 1988;14:687-695.